The novel oral gonadotropin‐releasing hormone receptor antagonist relugolix is a new option for controlled ovarian stimulation cycles

por Komiya, Shinnosuke, Tsuzuki‐Nakao, Tomoko, Asai, Yoshiko, Inoue, Tomoko, Morimoto, Yoshiharu, Okada, Hidetaka
Publicado 2022